Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia

Chronic myeloid leukemia in the blastic phase (CML-BP) responds poorly to clinical treatments and is usually fatal. In this study, we found that the histone H3 lysine 4 (H3K4) demethylase RBP2 (also called JARID1A and KDM5A) is underexpressed in CML-BP. The RBP2 histone demethylase stimulates leukem...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Minran, Zeng, Jiping, Wang, Xiaoming, Wang, Xiangyu, Huang, Tao, Fu, Yue, Sun, Ting, Jia, Jihui, Chen, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359230/
https://www.ncbi.nlm.nih.gov/pubmed/25575817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359230/
https://www.ncbi.nlm.nih.gov/pubmed/25575817

Ejemplares similares